NAM
CRL icon

Nexpoint Asset Management’s Charles River Laboratories CRL Stock Holding History

Nexpoint Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,354
Closed -$1.31M – 91
2025
Q3 		$1.31M Buy
8,354
+2,739
+49% +$435K 0.11% 67
2025
Q2 		$852K Buy
+5,615
New +$749K 0.08% 60
2020
Q3 		– Sell
-2,227
Closed -$388K – 172
2020
Q2 		$388K Sell
2,227
-405
-15% -$64.6K 0.09% 135
2020
Q1 		$332K Hold
2,632
– – 0.06% 153
2019
Q4 		$402K Hold
2,632
– – 0.03% 216
2019
Q3 		$349K Buy
+2,632
New +$353K 0.02% 274

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Nexpoint Asset Management's CRL Position: Q4 2025 in Review

Nexpoint Asset Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 8,354 shares — an estimated $1.31M sold.

Nexpoint Asset Management first reported a position in CRL in Q3 2019 and held it in 6 quarters. The position peaked at $1.31M in Q3 2025. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Nexpoint Asset Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Nexpoint Asset Management sold 8,354 Charles River Laboratories shares in Q4 2025, an estimated $1.31M.
  • Nexpoint Asset Management first reported a position in Charles River Laboratories in Q3 2019 and held it in 6 quarters.
  • Nexpoint Asset Management's Charles River Laboratories position peaked at $1.31M in Q3 2025.
  • 580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Nexpoint Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.